Cargando…
The Effect of Recombinant Human TSH on Sclerostin and Other Selected Bone Markers in Patients after Total Thyroidectomy for Differentiated Thyroid Cancer
The direct effect of TSH on bone metabolism in vivo is difficult to capture as the changes of its concentrations are followed by respective alterations of thyroid hormone levels. We evaluated the effect of recombinant human TSH (rhTSH) on sclerostin and other bone markers in 29 patients after total...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584503/ https://www.ncbi.nlm.nih.gov/pubmed/34768424 http://dx.doi.org/10.3390/jcm10214905 |
_version_ | 1784597465213698048 |
---|---|
author | Zygmunt, Arkadiusz Krawczyk-Rusiecka, Kinga Skowrońska-Jóźwiak, Elżbieta Wojciechowska-Durczyńska, Katarzyna Głowacka, Ewa Adamczewski, Zbigniew Lewiński, Andrzej |
author_facet | Zygmunt, Arkadiusz Krawczyk-Rusiecka, Kinga Skowrońska-Jóźwiak, Elżbieta Wojciechowska-Durczyńska, Katarzyna Głowacka, Ewa Adamczewski, Zbigniew Lewiński, Andrzej |
author_sort | Zygmunt, Arkadiusz |
collection | PubMed |
description | The direct effect of TSH on bone metabolism in vivo is difficult to capture as the changes of its concentrations are followed by respective alterations of thyroid hormone levels. We evaluated the effect of recombinant human TSH (rhTSH) on sclerostin and other bone markers in 29 patients after total thyroidectomy for differentiated thyroid cancer (DTC), without any signs of disease recurrence, who received L-thyroxine, most at non-suppressive doses. For two consecutive days, the patients were administered a standard dose of 0.9 mg rhTSH, i.m. Concentrations of sclerostin, osteocalcin, β-CrossLaps, PTH, and some other parameters, were measured before and five days after the first rhTSH administration. The greater the increase in TSH concentration (∆TSH), the greater the decrease in: ∆sclerostin (r = −0.672; p < 0.001), ∆β-CrossLaps (r = −0.580; p < 0.001) and ∆osteocalcin (r = −0.405; p = 0.029) levels, were recorded. The degree of TSH increase depended on the baseline PTH (r = 0.651; p < 0.001), age, and creatinine concentrations. rhTSH strongly inhibited bone turnover, thus, TSH—independently of thyroid hormones—exerted a direct protective effect on bone metabolism. Baseline PTH affected the magnitude of TSH increase and the degree of lowering in sclerostin and β-CrossLaps that suggest factors affecting PTH may play a role in the effect of TSH on the bone. |
format | Online Article Text |
id | pubmed-8584503 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85845032021-11-12 The Effect of Recombinant Human TSH on Sclerostin and Other Selected Bone Markers in Patients after Total Thyroidectomy for Differentiated Thyroid Cancer Zygmunt, Arkadiusz Krawczyk-Rusiecka, Kinga Skowrońska-Jóźwiak, Elżbieta Wojciechowska-Durczyńska, Katarzyna Głowacka, Ewa Adamczewski, Zbigniew Lewiński, Andrzej J Clin Med Article The direct effect of TSH on bone metabolism in vivo is difficult to capture as the changes of its concentrations are followed by respective alterations of thyroid hormone levels. We evaluated the effect of recombinant human TSH (rhTSH) on sclerostin and other bone markers in 29 patients after total thyroidectomy for differentiated thyroid cancer (DTC), without any signs of disease recurrence, who received L-thyroxine, most at non-suppressive doses. For two consecutive days, the patients were administered a standard dose of 0.9 mg rhTSH, i.m. Concentrations of sclerostin, osteocalcin, β-CrossLaps, PTH, and some other parameters, were measured before and five days after the first rhTSH administration. The greater the increase in TSH concentration (∆TSH), the greater the decrease in: ∆sclerostin (r = −0.672; p < 0.001), ∆β-CrossLaps (r = −0.580; p < 0.001) and ∆osteocalcin (r = −0.405; p = 0.029) levels, were recorded. The degree of TSH increase depended on the baseline PTH (r = 0.651; p < 0.001), age, and creatinine concentrations. rhTSH strongly inhibited bone turnover, thus, TSH—independently of thyroid hormones—exerted a direct protective effect on bone metabolism. Baseline PTH affected the magnitude of TSH increase and the degree of lowering in sclerostin and β-CrossLaps that suggest factors affecting PTH may play a role in the effect of TSH on the bone. MDPI 2021-10-24 /pmc/articles/PMC8584503/ /pubmed/34768424 http://dx.doi.org/10.3390/jcm10214905 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zygmunt, Arkadiusz Krawczyk-Rusiecka, Kinga Skowrońska-Jóźwiak, Elżbieta Wojciechowska-Durczyńska, Katarzyna Głowacka, Ewa Adamczewski, Zbigniew Lewiński, Andrzej The Effect of Recombinant Human TSH on Sclerostin and Other Selected Bone Markers in Patients after Total Thyroidectomy for Differentiated Thyroid Cancer |
title | The Effect of Recombinant Human TSH on Sclerostin and Other Selected Bone Markers in Patients after Total Thyroidectomy for Differentiated Thyroid Cancer |
title_full | The Effect of Recombinant Human TSH on Sclerostin and Other Selected Bone Markers in Patients after Total Thyroidectomy for Differentiated Thyroid Cancer |
title_fullStr | The Effect of Recombinant Human TSH on Sclerostin and Other Selected Bone Markers in Patients after Total Thyroidectomy for Differentiated Thyroid Cancer |
title_full_unstemmed | The Effect of Recombinant Human TSH on Sclerostin and Other Selected Bone Markers in Patients after Total Thyroidectomy for Differentiated Thyroid Cancer |
title_short | The Effect of Recombinant Human TSH on Sclerostin and Other Selected Bone Markers in Patients after Total Thyroidectomy for Differentiated Thyroid Cancer |
title_sort | effect of recombinant human tsh on sclerostin and other selected bone markers in patients after total thyroidectomy for differentiated thyroid cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584503/ https://www.ncbi.nlm.nih.gov/pubmed/34768424 http://dx.doi.org/10.3390/jcm10214905 |
work_keys_str_mv | AT zygmuntarkadiusz theeffectofrecombinanthumantshonsclerostinandotherselectedbonemarkersinpatientsaftertotalthyroidectomyfordifferentiatedthyroidcancer AT krawczykrusieckakinga theeffectofrecombinanthumantshonsclerostinandotherselectedbonemarkersinpatientsaftertotalthyroidectomyfordifferentiatedthyroidcancer AT skowronskajozwiakelzbieta theeffectofrecombinanthumantshonsclerostinandotherselectedbonemarkersinpatientsaftertotalthyroidectomyfordifferentiatedthyroidcancer AT wojciechowskadurczynskakatarzyna theeffectofrecombinanthumantshonsclerostinandotherselectedbonemarkersinpatientsaftertotalthyroidectomyfordifferentiatedthyroidcancer AT głowackaewa theeffectofrecombinanthumantshonsclerostinandotherselectedbonemarkersinpatientsaftertotalthyroidectomyfordifferentiatedthyroidcancer AT adamczewskizbigniew theeffectofrecombinanthumantshonsclerostinandotherselectedbonemarkersinpatientsaftertotalthyroidectomyfordifferentiatedthyroidcancer AT lewinskiandrzej theeffectofrecombinanthumantshonsclerostinandotherselectedbonemarkersinpatientsaftertotalthyroidectomyfordifferentiatedthyroidcancer AT zygmuntarkadiusz effectofrecombinanthumantshonsclerostinandotherselectedbonemarkersinpatientsaftertotalthyroidectomyfordifferentiatedthyroidcancer AT krawczykrusieckakinga effectofrecombinanthumantshonsclerostinandotherselectedbonemarkersinpatientsaftertotalthyroidectomyfordifferentiatedthyroidcancer AT skowronskajozwiakelzbieta effectofrecombinanthumantshonsclerostinandotherselectedbonemarkersinpatientsaftertotalthyroidectomyfordifferentiatedthyroidcancer AT wojciechowskadurczynskakatarzyna effectofrecombinanthumantshonsclerostinandotherselectedbonemarkersinpatientsaftertotalthyroidectomyfordifferentiatedthyroidcancer AT głowackaewa effectofrecombinanthumantshonsclerostinandotherselectedbonemarkersinpatientsaftertotalthyroidectomyfordifferentiatedthyroidcancer AT adamczewskizbigniew effectofrecombinanthumantshonsclerostinandotherselectedbonemarkersinpatientsaftertotalthyroidectomyfordifferentiatedthyroidcancer AT lewinskiandrzej effectofrecombinanthumantshonsclerostinandotherselectedbonemarkersinpatientsaftertotalthyroidectomyfordifferentiatedthyroidcancer |